+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Percutaneous Nephrolithotomy Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 197 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 5888915
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The percutaneous nephrolithotomy market is at a pivotal point, offering senior decision-makers opportunities to drive strategic growth through the adoption of next-generation clinical protocols, emerging medical devices, and agile regulatory responses. Guiding organizations through this evolution is essential for securing operational advantage within advanced endourological care.

Market Snapshot: Percutaneous Nephrolithotomy Market Growth and Direction

In 2024, the percutaneous nephrolithotomy market achieved a value of USD 19.66 billion, increasing to USD 21.27 billion for 2025 and set to progress at a CAGR of 8.24%, reaching USD 37.07 billion by 2032. This strong upward momentum reflects growing enthusiasm for minimally invasive urological approaches and a clear trend toward innovative device adoption. Hospitals and ambulatory surgical centers are central to this shift, prioritizing operational efficiency and quality outcomes. As stakeholders invest in technology upgrades, procedural precision, and improved care pathways, the sector increasingly serves as a core component of contemporary endourological practice.

Scope & Segmentation: Advancing Clinical, Technological, and Regional Boundaries

  • Product Types: Lithotripters, nephroscopes, baskets, dilators, guidewires, and sheaths address essential procedural steps, from stone fragmentation to safe access, ensuring comprehensive patient management during percutaneous nephrolithotomy procedures.
  • Procedure Types: Micro, mini, standard, and ultra mini techniques enable procedural flexibility across variable patient anatomies and differing levels of stone complexity, supporting personalized clinical planning.
  • End Users: Hospitals and ambulatory surgical centers remain the primary avenues for integrating advanced nephrolithotomy solutions, anchoring market demand and practical device utilization.
  • Technologies: Laser, pneumatic, and ultrasonic platforms are leveraged to optimize procedural efficiency, precision, and outcomes for distinct clinical requirements.
  • Applications: Selection of medical devices is typically informed by the nature of the stone, with interventions tailored for renal and staghorn calculi, facilitating targeted and effective treatments.
  • Patient Types: Adult and pediatric patient protocols are distinctly considered, ensuring that procedural approaches account for anatomical and physiological differences for safe and suitable outcomes.
  • Regions: The Americas, Europe, Middle East & Africa, and Asia-Pacific each define market direction through adoption patterns, healthcare infrastructure, and localized production. These regional differences shape supplier priorities and purchaser preferences, with some areas emphasizing compliance and others focusing on accelerating technology adoption or domestic manufacturing.

Percutaneous Nephrolithotomy Market: Key Takeaways for Senior Decision-Makers

  • Minimally invasive stone removal procedures are prioritized, leading to better recovery for patients and improved allocation of clinical resources.
  • Device miniaturization along with advanced imaging technologies, such as three-dimensional visualization, allows for enhanced surgical precision, greater patient safety, and streamlined clinical workflows.
  • Integration of artificial intelligence and image fusion facilitates improved procedural planning, enabling workflows that are increasingly aligned with patient-specific requirements.
  • Procurement strategies are maturing, emphasizing adaptive sourcing, local supplier partnerships, and resilient supply chains to navigate external and economic fluctuations effectively.
  • Regional variability requires nuanced market strategies: North America is characterized by early technology adoption, Europe emphasizes systematic compliance, and Asia-Pacific leverages rapid investment along with expanded domestic production.
  • Ongoing product diversification, research investment, and strategic partnerships both support regulatory navigation and foster clinical advancement in this dynamic market.

Tariff Impact: Navigating Cost Structures and Supply Chain Adjustments

Recent US tariff adjustments have influenced healthcare procurement models, prompting a reassessment of capital expenditure and vendor risk. This shift supports value-based contracts and a more prominent role for domestic and nearshore suppliers. Enhanced inventory controls, rigorous compliance, and reassessment of reimbursement methods have emerged as new best practices. Cooperation between procurement and clinical teams is crucial for optimizing equipment investment and responding to changing market dynamics.

Methodology & Data Sources

The report draws on structured interviews with urologists, procurement experts, and healthcare administrators, combined with analysis of peer-reviewed publications and most recent regulatory guidance. Both quantitative and qualitative data are integrated and undergo subject-matter expert validation for each segment and technology discussed.

Why This Report Matters: Strategic Insights for Senior Leaders

  • Offers actionable intelligence for procurement planning, capital allocation, and partnership decisions amid evolving percutaneous nephrolithotomy market conditions.
  • Clarifies the influence of trends across product, procedure, and regional segments to support more collaborative and strategic organizational alignment.
  • Outlines how regulatory shifts and innovations in supply chain management can shape robust growth strategies, risk mitigation, and long-term investment planning.

Conclusion

Sustained progress in the percutaneous nephrolithotomy market requires strategic adoption of emerging technology, resilient supply chains, and ongoing workforce upskilling. Organizations aligning business planning with clinical and market trends will be well positioned for continued competitive advantage and growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Rising adoption of miniaturized percutaneous nephrolithotomy systems in ambulatory centers
5.2. Integration of advanced imaging technologies to enhance percutaneous nephrolithotomy precision
5.3. Growing focus on single-step stone fragmentation devices to reduce procedure times and complications
5.4. Increasing utilization of ultrasound guidance over fluoroscopy to minimize radiation exposure in PCNL
5.5. Development of robotic-assisted percutaneous nephrolithotomy platforms for improved surgical outcomes
5.6. Expansion of outpatient percutaneous nephrolithotomy services driven by cost containment initiatives
5.7. Rising demand for disposable PCNL accessories to address infection control and sterilization challenges
5.8. Advancements in augmented reality visualization aiding precise renal access during nephrolithotomy procedures
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Percutaneous Nephrolithotomy Market, by Product Type
8.1. Accessories
8.1.1. Baskets
8.1.2. Dilators
8.1.3. Guidewires
8.1.4. Sheaths
8.2. Lithotripters
8.3. Nephroscopes
9. Percutaneous Nephrolithotomy Market, by Procedure Type
9.1. Micro
9.2. Mini
9.3. Standard
9.4. Ultra Mini
10. Percutaneous Nephrolithotomy Market, by End User
10.1. Ambulatory Surgical Centers
10.1.1. Freestanding Centers
10.1.2. Hospital Based Centers
10.2. Hospitals
10.2.1. Private Hospitals
10.2.2. Public Hospitals
11. Percutaneous Nephrolithotomy Market, by Technology
11.1. Laser
11.2. Pneumatic
11.3. Ultrasonic
12. Percutaneous Nephrolithotomy Market, by Application
12.1. Renal Calculi
12.2. Staghorn Calculi
13. Percutaneous Nephrolithotomy Market, by Patient Type
13.1. Adult
13.2. Pediatric
14. Percutaneous Nephrolithotomy Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Percutaneous Nephrolithotomy Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Percutaneous Nephrolithotomy Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Boston Scientific Corporation
17.3.2. KARL STORZ SE & Co. KG
17.3.3. Olympus Corporation
17.3.4. Richard Wolf GmbH
17.3.5. Stryker Corporation
17.3.6. Cook Medical LLC
17.3.7. Teleflex Incorporated
17.3.8. CONMED Corporation
17.3.9. Dornier MedTech GmbH
17.3.10. Lumenis Ltd.
List of Tables
List of Figures

Samples

Loading
LOADING...

Companies Mentioned

The key companies profiled in this Percutaneous Nephrolithotomy market report include:
  • Boston Scientific Corporation
  • KARL STORZ SE & Co. KG
  • Olympus Corporation
  • Richard Wolf GmbH
  • Stryker Corporation
  • Cook Medical LLC
  • Teleflex Incorporated
  • CONMED Corporation
  • Dornier MedTech GmbH
  • Lumenis Ltd.

Table Information